Research Article
Clinical Impact of Viral Load on the Development of Hepatocellular Carcinoma and Liver-Related Mortality in Patients with Hepatitis C Virus Infection
Table 1
Baseline characteristics of enrolled subjects.
| | Characteristics | Values |
| | Age, year | 53 ± 13 |
| | Male gender, (%) | 54 (48.6) |
| | Initial presence of cirrhosis, (%) | 29 (26.1) |
| | Child-Pugh classification, (%) | | | A | 78 (70.3) | | B | 26 (23.4) | | C | 7 (6.3) |
| | Alanine aminotransferase, IU/L | 80 ± 84 |
| | Bilirubin, mg/dL | 1.2 ± 1.8 |
| | Prothrombin time, INR | 1.2 ± 0.3 |
| | Platelet, 103/mm3 | 164 ± 67 |
| | Albumin, g/dL | 4.1 ± 0.6 |
| | Creatinine, mg/dL | 0.9 ± 1.2 |
| | HCV RNA (log IU/mL), (%) | | | Low (≦) | 59 (53.2) | | High (>) | 52 (46.8) |
| | HCV genotype, (%) | | | 1b | 39/75 (52.0) | | Non-1b | 36/75 (48.0) | | Not checked | 36/111 (32.4) |
| | Antiviral therapy, (%) | | | No | 68/111 (61.3) | | Yes | 43/111 (38.7) |
| | Sustained virologic response, (%) | | | No | 12/43 (28.0) | | Yes | 31/43 (72.0) |
| | Follow-up duration, months | 54 ± 16 |
|
|
Data are the number (percentage) or mean standard deviation.
HCV: hepatitis C virus.
|
